Table 4.
Pain score and WOMAC total score in the participants.
| Subjects using bisphosphonate in previous 5 years | Subjects using bisphosphonate in previous 30 days | |||||
|---|---|---|---|---|---|---|
| Non-use | Use | P | Non-use | Use | P | |
| Baseline pain score | 2.73 ± 2.85 | 3.35 ± 2.37 | 0.26 | 3.05 ± 2.87 | 3.29 ± 2.27 | 0.70 |
| The change of pain score | 0.77 ± 3.19 | 0.35 ± 2.72 | 0.50 | 0 ± 3.04 | 0.08 ± 2.99 | 0.90 |
| Baseline WOMAC total score | 15.39 ± 15.96 | 15.94 ± 13.57 | 0.86 | 14.97 ± 15.96 | 15.22 ± 13.60 | 0.94 |
| The change of total score | −0.52 ± 11.78 | 0.12 ± 10.69 | 0.78 | −4.01 ± 12.01 | 0.37 ± 11.23 | 0.12 |